Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice
Maddison R Johnstone, Mujun Sun, Caroline J Taylor, Rhys D Brady, Brian L Grills, Jarrod E Church, Sandy R Shultz, Stuart J McDonald
Brain Injury | TAYLOR & FRANCIS LTD | Published : 2018
This work was supported by funding to SJM through the Understanding Disease RFA of La Trobe University and to SRS from the Australian National Health and Medical Research Council. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the content of this article.